About: Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

scientific article published on 05 June 2009

Attributes	Values
rdf:type	Item
description	videnskabelig artikel (da) article científic (ca) articolo scientifico (it) artigo científico (pt) bilimsel makale (tr) vedecký článok (sk) vetenskaplig artikel (sv) vědecký článek (cs) wetenschappelijk artikel (nl) wissenschaftlicher Artikel (de) научни чланак (sr) article scientifique (fr) artículu científicu espublizáu en 2009 (ast) наукова стаття, опублікована в червні 2009 (uk) مقالة علمية نشرت في 05 يونيو 2009 (ar) scientific article published on 05 June 2009 (en)
publication date	wds:Q37244962-4550730F-65B3-4E0B-8E58-61D1309AEC77
publication date	2009-06-05 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q37244962-A4675DC9-224C-46A9-AC60-21A5EB42D71D
language of work or name	English
exact match	wds:Q37244962-A1FBF5E4-B8FE-472F-82A7-2B79D28A38A5
exact match	https://scigraph.springernature.com/pub.10.1186/1476-511x-8-19
cites work	wds:Q37244962-0A00E830-8E35-43F6-91E0-F5032000D727 wds:Q37244962-0DA6274A-34FA-4DE9-8D8A-1C4D9AEAC068 wds:Q37244962-0F32CB53-A9FF-4948-8122-E6AF4A87C070 wds:Q37244962-1EA59E34-AC3D-4C06-A270-E860543EC2A4 wds:Q37244962-2148F799-A365-44FD-845D-2374402D3EC6 wds:Q37244962-2864614C-7F1B-4AE2-90FF-A655392B9B4D wds:Q37244962-28B070FC-35DD-441F-9A84-7AEEC7CD5174 wds:Q37244962-2956C3C1-DA66-48CE-A309-347E9D41BB5F wds:Q37244962-2BAA264A-B15B-44DB-9F81-142B7D184D04 wds:Q37244962-3354D671-A142-4EF9-A983-53231ACA21E0 wds:Q37244962-3534CBC2-1271-486D-BFEE-8AB8C767B9E6 wds:Q37244962-3D94ECFA-41B3-40A5-ADD9-CCFD9F5CA953 wds:Q37244962-4559E5E8-1008-44B0-9E03-33C5A9EB0DD9 wds:Q37244962-468A918C-EB03-414D-B24E-0308AC264BFB wds:Q37244962-4CAFE9E2-6A8F-4ECF-9040-F153D742E2C5 wds:Q37244962-512EA303-CF61-4566-9025-85DA02E4F881 wds:Q37244962-5D0CCAB1-B23C-4E02-B952-78BAA860AF48 wds:Q37244962-72C3AB89-56B9-49F5-B0D1-A9E1B89BD8B0 wds:Q37244962-735BCA0E-657A-4410-A9DD-5D77976D3B7F wds:Q37244962-75E62711-80E5-4636-871E-7C0510650B02 wds:Q37244962-7B97B47C-B1D3-455A-A3FD-A4ECDFADF169 wds:Q37244962-893B4585-5F8F-4B30-A69E-9D83A225D7F8 wds:Q37244962-94436DF8-9598-4726-A6F0-E9823646F98D wds:Q37244962-AA2B0C42-B8DF-4B80-8E39-5F3B5BD5A29E wds:Q37244962-B0C4A3E2-A0B6-413F-9ACD-38B22BC5EECF wds:Q37244962-B2C65B94-7743-4C98-B55C-AB688EE30CC6 wds:Q37244962-B4C3B1CE-8B2B-4FCA-BE6C-567B91F6EA53 wds:Q37244962-CF068279-386F-4D64-9A09-785AB9A0AD73 wds:Q37244962-D049341D-EEB0-4F43-A6FE-C0751FA72F76 wds:Q37244962-D119BD62-8D79-43F5-A534-3E50D427255F wds:Q37244962-D6C9799A-A786-47E8-B582-D4708BFA9366 wds:Q37244962-DA4209D2-0E43-4090-A4BA-B4491BDA4B31 wds:Q37244962-DAC6CC52-9C5A-4B26-AFF4-E13F7D4C5A7C wds:Q37244962-E849A186-373A-42FE-B4BC-7B4ED99AFD45 wds:Q37244962-EB1446D4-53C0-40C3-9813-5E9E8EB2CFB1 wds:Q37244962-EB90EF86-C3BD-46A1-9484-313317F1D0C8
cites work	Elevated Lp-PLA 2 Levels Add Prognostic Information to the Metabolic Syndrome on Incidence of Cardiovascular Events Among Middle-Aged Nondiabetic Subjects Validity and reliability of dual-energy X-ray absorptiometry for the assessment of abdominal adiposity Influence of race and sex on lipoprotein-associated phospholipase A2 levels: observations from the Dallas Heart Study. The International Physical Activity Questionnaire (IPAQ): a study of concurrent and construct validity. The role of lipoprotein-associated phospholipase A2 in atherosclerosis may depend on its lipoprotein carrier in plasma Visceral Fat Adipokine Secretion Is Associated With Systemic Inflammation in Obese Humans The relation of body fat mass and distribution to markers of chronic inflammation Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Increased plasma non-esterified fatty acids and platelet-activating factor acetylhydrolase are associated with susceptibility to atherosclerosis in mice Lipoprotein-associated phospholipase A2 is an independent predictor of incident coronary heart disease in an apparently healthy older population: the Rancho Bernardo Study Intracellular PAF catabolism by PAF acetylhydrolase counteracts continual PAF synthesis Indices of abdominal obesity are better discriminators of cardiovascular risk factors than BMI: a meta-analysis. Macrophage infiltration into omental versus subcutaneous fat across different populations: effect of regional adiposity and the comorbidities of obesity The association between lipoprotein-associated phospholipase A2 and cardiovascular disease and total mortality in vascular medicine patients Review of the evidence for the clinical utility of lipoprotein-associated phospholipase A2 as a cardiovascular risk marker The epidemiology of Lp-PLA(2): distribution and correlation with cardiovascular risk factors in a population-based cohort Effects of a low-calorie diet associated with weight loss on lipoprotein-associated phospholipase A2 (Lp-PLA2) activity in healthy obese women. Characterization of a platelet activating factor acetylhydrolase from rat adipocyte Lipoprotein-associated PAF-acetylhydrolase activity in subjects with the metabolic syndrome Platelet-activating factor. Evidence for 1-O-alkyl-2-acetyl-sn-glyceryl-3-phosphorylcholine as the active component (a new class of lipid chemical mediators) Role of lipoprotein-associated phospholipase A2 in leukocyte activation and inflammatory responses Platelet-activating factor formation during oxidative modification of low-density lipoprotein when PAF-acetylhydrolase has been inactivated Sarcopenia, obesity, and inflammation--results from the Trial of Angiotensin Converting Enzyme Inhibition and Novel Cardiovascular Risk Factors study Lipoprotein-associated phospholipase A2 adds to risk prediction of incident coronary events by C-reactive protein in apparently healthy middle-aged men from the general population: results from the 14-year follow-up of a large cohort from southern G Lipoprotein-associated phospholipase A2, high-sensitivity C-reactive protein, and risk for incident coronary heart disease in middle-aged men and women in the Atherosclerosis Risk in Communities (ARIC) study Distribution and correlates of lipoprotein-associated phospholipase A2 in an elderly cohort: the Cardiovascular Health Study Lipoprotein-associated phospholipase A2 activity is a marker of small, dense LDL particles in human plasma Lipoprotein-associated phospholipase A2 activity and risk of heart failure: The Rotterdam study Prevalence and cluster of cardiometabolic biomarkers in overweight and obese schoolchildren: results from a large survey in southwest Germany TNFalpha is a potent inducer of platelet-activating factor synthesis in adipocytes but not in preadipocytes. Differential regulation by PI3K. Platelet-activating factor acetylhydrolase concentration in children with abdominal obesity Value of the sagittal abdominal diameter in coronary heart disease risk assessment: cohort study in a large, multiethnic population Fatty acids increase the circulating levels of oxidative stress factors in mice with diet-induced obesity via redox changes of albumin Smoking induces lipoprotein-associated phospholipase A2 in cardiovascular disease free adults: the ATTICA Study. Platelet activating factor (PAF) and activity of its biosynthetic and catabolic enzymes in blood and leukocytes of male patients with newly diagnosed heart failure.
rdfs:label	Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults (en) Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults (nl) Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults (ast)
skos:prefLabel	Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults (en) Lipoprotein-associated phospholipase A2 (Lp-PLA2) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults (nl)

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 193 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software